Banking Law and Virtual Healthcare Economies in Spain — Detailed Explanation with Case Laws

1. Introduction

“Virtual healthcare economies” describes the financial ecosystem surrounding digitally delivered healthcare: telemedicine, health apps, remote diagnostics, electronic prescriptions, digital therapeutics, AI-assisted healthcare, online pharmacies, wearable-device services, health-data platforms and healthcare marketplaces.

Spain does not have a single statute called the “Virtual Healthcare Economy Law.” From a banking-law perspective, these businesses sit at the intersection of several regimes:

• Spanish banking and credit law;
• EU payment-services regulation;
• AML/CFT rules;
• consumer-credit and consumer-protection law;
• GDPR and Spanish data-protection law;
• electronic-commerce regulation;
• healthcare and patient-autonomy legislation;
• medical-device regulation;
• cybersecurity and operational-resilience requirements; and
• EU rules governing digital platforms and artificial intelligence.

The key banking-law question is therefore not simply whether virtual healthcare is lawful. It is how banks, payment providers and investors may finance, process payments for, safeguard funds for and manage risks arising from digital healthcare businesses in Spain.

2. Spanish Banking Regulatory Framework

Spain's principal banking supervisor is the Banco de España, while significant credit institutions are supervised within the European Central Bank's Single Supervisory Mechanism.

Important banking legislation includes Law 10/2014 on the organisation, supervision and solvency of credit institutions.

A bank financing a virtual healthcare company must apply normal prudential standards even where the underlying business is highly technological.

For example, a Spanish bank lending €10 million to a telemedicine platform should consider:

Credit risk: Can subscription and consultation revenue support repayment?

Regulatory risk: Is the healthcare service legally authorized?

Technology risk: Could a major system failure disrupt revenue?

Data risk: Does the company lawfully process sensitive health information?

Operational risk: How dependent is it on cloud providers or third-party software?

Reputational risk: Could unsafe healthcare practices damage the bank's reputation?

Thus, healthcare regulation can indirectly become relevant to the bank's credit decision.

3. Financing Telemedicine Companies

Spanish banks may provide ordinary corporate financing to telemedicine businesses.

Possible structures include:

• term loans;
• revolving credit facilities;
• equipment financing;
• venture debt;
• receivables financing;
• acquisition financing; and
• working-capital facilities.

Suppose Madrid Digital Health S.L. provides remote medical consultations and receives monthly subscription payments.

A bank could provide a revolving facility secured, where legally appropriate, against business assets or qualifying receivables.

However, the lender should examine whether the platform's income is legally and commercially sustainable.

A business model dependent on unlawful medical advertising, invalid patient consent or unauthorized professional services represents significantly greater credit risk.

4. Payments in Virtual Healthcare

Payments are fundamental to virtual healthcare economies.

Patients may pay for:

• online consultations;
• prescriptions;
• diagnostic services;
• subscription plans;
• digital therapeutics;
• wearable monitoring;
• insurance-related services; and
• pharmacy products.

Where an entity itself provides regulated payment services, the EU payment-services framework and Spanish implementing legislation, particularly Royal Decree-Law 19/2018, become relevant.

A healthcare marketplace cannot necessarily collect and redistribute money among patients, doctors, clinics and pharmacies however it chooses.

Its business model must be analyzed to determine whether it is merely receiving payment for its own services or performing a regulated payment service for third parties.

5. Healthcare Marketplace Example

Consider an app called SaludVirtual España.

The patient pays €80 through the app:

• €60 belongs to the doctor;
• €15 is the platform's commission;
• €5 represents another service charge.

If the platform receives and controls money belonging to the doctor before transferring it, payment-services questions may arise.

One possible solution could involve using an appropriately authorized payment service provider.

This distinction is important because technology does not remove financial-regulatory licensing requirements.

6. PSD2 and Strong Customer Authentication

Remote healthcare transactions frequently occur entirely online.

Accordingly, payment authentication requirements can be particularly important.

PSD2 and its associated regulatory framework introduced Strong Customer Authentication (SCA) for many electronic payments.

SCA generally involves authentication based on independent elements from categories involving:

1. knowledge;
2. possession; and
3. inherence,

subject to applicable rules and exemptions.

A patient paying a telemedicine provider through a card or other regulated electronic payment channel may therefore encounter authentication requirements imposed through the payment ecosystem.

Healthcare convenience does not automatically displace payment-security requirements.

7. AML/CFT Obligations

Spain's principal AML legislation is Law 10/2010 on the prevention of money laundering and terrorist financing, supplemented by implementing rules.

Banks supporting virtual healthcare businesses must conduct customer due diligence on their corporate clients.

The institution may need to understand:

• ownership;
• beneficial ownership;
• directors and controllers;
• business model;
• expected transaction volumes;
• geographic exposure;
• source of funds; and
• unusual transaction patterns.

A healthcare label does not automatically indicate low financial-crime risk.

For example, a supposedly small telemedicine provider receiving extremely large international transfers unrelated to its stated customer base may justify investigation.

8. Beneficial Ownership

If a virtual healthcare company seeks a Spanish banking relationship, the bank must identify the company and determine its relevant beneficial ownership under applicable AML requirements.

Suppose the company is incorporated in Spain but owned through several foreign holding companies.

The bank cannot stop at:

“The applicant is a healthcare technology company.”

It must understand the relevant ownership and control structure.

Digital-health innovation therefore remains subject to conventional banking transparency requirements.

9. Health Data as Special-Category Data

One of the defining characteristics of virtual healthcare is its reliance on personal information.

Under Article 9 GDPR, data concerning health falls within special categories of personal data and generally receives heightened protection.

Spain additionally operates under Organic Law 3/2018 on Personal Data Protection and guarantee of digital rights (LOPDGDD).

This creates an important boundary for banks.

A bank may legitimately require financial information to evaluate a healthcare company's creditworthiness, but this does not mean that it should obtain individual patients' medical histories.

Example

A lender considering financing for a digital clinic may legitimately analyze:

• aggregate subscription revenue;
• invoices;
• cash flow;
• churn rates; and
• accounts receivable.

That does not automatically justify obtaining identifiable information about individual patients' diagnoses.

The principles of purpose limitation and data minimization are therefore particularly important.

10. Financing Against Healthcare Receivables

Virtual healthcare businesses can generate substantial receivables.

These may arise from:

• private patients;
• insurers;
• corporate healthcare plans;
• clinics;
• public-sector contracts; and
• subscription arrangements.

Banks can potentially provide receivables financing, factoring or other working-capital facilities.

However, healthcare receivables can create complications concerning confidentiality, assignment, reimbursement conditions and personal data.

The bank must structure financing so that obtaining financial rights does not unnecessarily expose it to sensitive medical information.

11. Consumer Credit for Virtual Healthcare

Another growing issue is healthcare financing.

Suppose a private digital healthcare provider offers a €3,000 treatment and allows the patient to finance the cost through a lender.

Depending on the structure, Spanish and EU consumer-credit requirements can become relevant.

Important considerations can include:

• pre-contractual disclosure;
• creditworthiness assessment;
• interest and charges;
• advertising;
• withdrawal rights;
• unfair terms; and
• transparency.

Calling a product a “health payment plan” does not prevent it from being legally characterized as credit where its substance constitutes consumer financing.

12. Buy Now, Pay Later and Healthcare

BNPL arrangements may also enter virtual healthcare markets.

For example:

Treatment today → installments over six months.

The legal treatment depends upon the precise structure and applicable consumer-credit framework.

Banks and fintech lenders must be especially careful because healthcare consumers may be making financial decisions while under significant personal pressure.

Transparent pricing and responsible credit assessment are consequently important.

13. Electronic Contracts

Virtual healthcare depends heavily on digital contracting.

Spain's Law 34/2002 on Information Society Services and Electronic Commerce (LSSI-CE) forms part of the relevant legal framework for electronic services and contracting.

Banks may therefore encounter digitally generated:

• subscription agreements;
• treatment-service contracts;
• financing agreements;
• payment mandates;
• electronic invoices; and
• consent records.

The enforceability and evidential reliability of electronic records become important when these documents underpin financing.

14. AI-Based Healthcare Platforms

AI increasingly influences:

• symptom assessment;
• medical imaging;
• patient prioritization;
• appointment management;
• clinical decision support; and
• remote monitoring.

For banks, AI risk becomes relevant when evaluating the business sustainability of a borrower.

The EU Artificial Intelligence Act (Regulation (EU) 2024/1689) introduces a risk-based regulatory regime for AI systems. Certain healthcare-related AI systems can fall within particularly demanding categories depending on their intended purpose and regulatory status.

A bank financing an AI-health company should therefore examine whether the company's business model depends on technology subject to significant regulatory requirements.

15. Medical Devices

Some digital healthcare products can constitute medical devices.

The principal EU framework includes:

• Regulation (EU) 2017/745 — Medical Device Regulation (MDR); and
• Regulation (EU) 2017/746 — In Vitro Diagnostic Medical Devices Regulation (IVDR).

Software can potentially qualify as a medical device depending upon its intended medical purpose.

Banking consequence

Suppose a startup seeks €15 million to commercialize diagnostic software.

If commercialization depends on regulatory conformity that has not yet been achieved, the bank faces substantial regulatory milestone risk.

The loan agreement might therefore incorporate appropriate conditions precedent, representations, reporting requirements or other contractual protections.

16. Cybersecurity and Operational Resilience

Virtual healthcare businesses can be highly dependent on cloud infrastructure and continuous connectivity.

A major cyberattack can:

• interrupt medical services;
• compromise patient information;
• disrupt payment processing;
• generate regulatory liability; and
• materially reduce company revenue.

Banks must therefore consider cyber risk as part of credit and operational-risk analysis.

For financial institutions themselves, the Digital Operational Resilience Act (DORA), Regulation (EU) 2022/2554, establishes extensive ICT-risk requirements.

DORA is particularly relevant where banks depend upon technology providers and other ICT third parties.

17. Platform and Concentration Risk

A virtual healthcare company may rely heavily upon one:

• cloud provider;
• payment processor;
• insurer;
• hospital network;
• app marketplace; or
• AI provider.

This creates concentration risk.

A bank conducting credit analysis should determine what happens if that relationship terminates.

For example, if 75% of a telemedicine company's revenue comes from one insurer, loss of that contract may seriously impair debt-service capacity.

18. Securitisation Possibilities

As virtual healthcare businesses mature, portfolios of predictable receivables could potentially support structured financing.

EU securitisation is principally regulated by Regulation (EU) 2017/2402.

A lender considering securitisation of healthcare-related receivables must distinguish between the financial asset and underlying sensitive healthcare information.

The financing structure should not result in unnecessary circulation of identifiable patient medical data.

19. Relevant Case Laws

There is no large Spanish body of reported judgments specifically labelled “banking law and virtual healthcare economies.” The subject is an intersection of several legal fields. The following decisions provide important principles.

Case 1 — Google Spain SL and Google Inc. v AEPD and Mario Costeja González, C-131/12, CJEU (2014)

The CJEU established major principles concerning EU data-protection rights in the digital environment.

Relevance: Virtual healthcare companies operate digitally and process exceptionally sensitive information. Digital business models do not escape European data-protection obligations merely because information is processed through an online platform.

For banks, this reinforces the importance of assessing the data-law exposure of technology-dependent borrowers.

Case 2 — Digital Rights Ireland Ltd, Joined Cases C-293/12 and C-594/12, CJEU (2014)

The Court invalidated the Data Retention Directive because of disproportionate interference with fundamental rights.

Principle: Large-scale collection and retention of personal information require strong justification and safeguards.

Virtual-health relevance: indiscriminate accumulation of patient-related information can create significant legal risk.

A lender conducting due diligence should therefore request information proportionate to its legitimate financial purpose rather than demanding entire patient databases.

Case 3 — Schrems II, C-311/18, CJEU (2020)

The CJEU invalidated the EU-US Privacy Shield and emphasized safeguards surrounding international personal-data transfers.

Relevance: Spanish virtual healthcare businesses frequently depend on international cloud and software infrastructure.

Cross-border processing of health information can therefore create significant compliance risk, which can also affect lenders and investors evaluating the company.

Case 4 — Orange România SA v ANSPDCP, C-61/19, CJEU (2020)

The CJEU addressed requirements surrounding valid consent under EU data-protection law.

Principle: consent must satisfy substantive requirements and cannot simply be presumed from inadequate documentation or procedures.

Virtual-health relevance: healthcare platforms should distinguish carefully among contractual acceptance, medical consent and GDPR consent. These concepts are not automatically interchangeable.

Case 5 — Bundesverband der Verbraucherzentralen v Planet49 GmbH, C-673/17, CJEU (2019)

The Court considered consent in the context of cookies and online services.

Principle: valid consent requires meaningful affirmative action in circumstances where consent is the appropriate legal basis.

Relevance: virtual healthcare platforms cannot treat passive digital behavior as universal permission for every type of personal-data processing.

Case 6 — VB Pénzügyi Lízing Zrt v Ferenc Schneider, C-137/08, CJEU (2010)

This consumer-law case emphasized judicial scrutiny of potentially unfair contractual terms.

Banking relevance: digital healthcare financing contracts remain subject to consumer-law protections. The fact that credit is offered through an app does not remove scrutiny of unfair contractual terms.

Case 7 — Aziz v Caixa d'Estalvis de Catalunya, Tarragona i Manresa (Catalunyacaixa), C-415/11, CJEU (2013)

This important Spanish reference concerned unfair terms in consumer contracts.

The CJEU strengthened effective consumer protection against unfair contractual provisions.

Virtual-health financing relevance: banks financing healthcare services must ensure consumer-credit terms are transparent and compatible with EU unfair-terms rules.

The digital nature of the transaction does not reduce consumer protection.

Case 8 — Banco Español de Crédito SA v Joaquín Calderón Camino, C-618/10, CJEU (2012)

Another highly relevant Spanish banking/consumer decision.

The Court considered unfair terms in a consumer-credit relationship and the responsibilities of national courts under EU consumer law.

Relevance: where Spanish banks or lenders finance virtual healthcare purchases, ordinary consumer protections continue to apply to digitally concluded credit agreements.

20. Integrated Compliance Model

A Spanish bank evaluating a virtual healthcare business can use the following structure:

Healthcare company
↓
Corporate and beneficial-owner KYC
↓
AML/CFT risk assessment
↓
Healthcare authorization assessment
↓
Medical-device/AI regulatory analysis where relevant
↓
GDPR and health-data assessment
↓
Payment-services analysis
↓
Cybersecurity and technology review
↓
Revenue and receivables analysis
↓
Consumer-protection review
↓
Credit decision
↓
Contractual safeguards
↓
Ongoing monitoring

This illustrates an important point: banking supervision and healthcare regulation remain legally separate, but economically they interact.

21. Major Banking Risks

For Spanish banks, the virtual healthcare economy creates five especially significant categories of risk.

Credit risk: a healthcare platform may lose licenses, customers or reimbursement contracts.

Compliance risk: payment, AML, consumer or healthcare rules may be violated.

Data risk: health information receives particularly strong protection under GDPR.

Technology risk: cyber incidents or infrastructure failures may interrupt the business.

Regulatory-change risk: AI, digital health and platform regulation continue to develop rapidly.

Banks should therefore avoid assessing these companies solely as conventional software startups.

22. Future Development

Spain's virtual healthcare economy is likely to become increasingly connected with AI, wearable devices, electronic identity, instant payments, digital insurance, cloud computing and remote patient monitoring.

That will deepen the relationship between healthcare regulation and banking law.

A future digital-health company might simultaneously be:

• a healthcare provider;
• an AI deployer;
• a medical-device operator;
• an online marketplace;
• a processor of special-category data;
• a borrower from banks; and
• a participant in a regulated payment structure.

Its legal classification must therefore be determined function by function, rather than from the company's description of itself as a “health-tech platform.”

Conclusion

Banking law and virtual healthcare economies in Spain represent a cross-sector regulatory field rather than a standalone branch of Spanish banking law. Spanish banks can finance telemedicine providers, digital-health startups, medical-AI companies and related infrastructure, but ordinary prudential, AML/CFT, payment and consumer-credit obligations continue to apply.

The regulatory framework becomes particularly demanding because virtual healthcare combines money with sensitive health information. GDPR, LOPDGDD, Law 10/2010, Law 10/2014, Spain's payment-services framework, electronic-commerce legislation, EU medical-device rules and increasingly the EU AI Act all potentially affect the economic viability of these businesses.

The case law—including Google Spain*, Digital Rights Ireland, Schrems II, Orange România, Planet49, VB Pénzügyi Lízing, Aziz and *Banco Español de Crédito—demonstrates a consistent European principle: digitisation does not remove established protections for consumers, personal data or regulated financial activity.

For Spanish banks, the safest approach is therefore to treat virtual healthcare financing as multidimensional regulated lending: assess the borrower not only for repayment capacity, but also for healthcare authorization, payment structure, AML compliance, consumer protection, health-data governance, AI/medical-device compliance and cybersecurity resilience.